| Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Y Tanaka, N Nishida, M Sugiyama, M Kurosaki, K Matsuura, N Sakamoto, ... Nature genetics 41 (10), 1105-1109, 2009 | 2764 | 2009 |
| Influence of hepatitis B virus genotypes on the intra‐and extracellular expression of viral DNA and antigens M Sugiyama, Y Tanaka, T Kato, E Orito, K Ito, SK Acharya, RG Gish, ... Hepatology 44 (4), 915-924, 2006 | 332 | 2006 |
| Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection A Ozasa, Y Tanaka, E Orito, M Sugiyama, JH Kang, S Hige, T Kuramitsu, ... Hepatology 44 (2), 326-334, 2006 | 313 | 2006 |
| Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide … K Watashi, A Sluder, T Daito, S Matsunaga, A Ryo, S Nagamori, ... Hepatology 59 (5), 1726-1737, 2014 | 297 | 2014 |
| An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region T Nakano, GMG Lau, GML Lau, M Sugiyama, M Mizokami Liver international 32 (2), 339-345, 2012 | 203 | 2012 |
| Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection K Murata, M Asano, A Matsumoto, M Sugiyama, N Nishida, E Tanaka, ... Gut 67 (2), 362-371, 2018 | 171 | 2018 |
| Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean N Nishida, H Sawai, K Matsuura, M Sugiyama, SH Ahn, JY Park, S Hige, ... PloS one 7 (6), e39175, 2012 | 165 | 2012 |
| Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors M Kurosaki, Y Tanaka, N Nishida, N Sakamoto, N Enomoto, M Honda, ... Journal of hepatology 54 (3), 439-448, 2011 | 146 | 2011 |
| Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon‐λ in response to hepatitis C virus S Yoshio, T Kanto, S Kuroda, T Matsubara, K Higashitani, N Kakita, ... Hepatology 57 (5), 1705-1715, 2013 | 127 | 2013 |
| Candesartan reduces oxidative stress and inflammation in patients with essential hypertension Y Dohi, M Ohashi, M Sugiyama, H Takase, K Sato, R Ueda Hypertension Research 26 (9), 691-697, 2003 | 127 | 2003 |
| Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity S Shimura, K Watashi, K Fukano, M Peel, A Sluder, F Kawai, M Iwamoto, ... Journal of hepatology 66 (4), 685-692, 2017 | 126 | 2017 |
| Effects of atorvastatin on inflammation and oxidative stress M Sugiyama, M Ohashi, H Takase, K Sato, R Ueda, Y Dohi Heart and Vessels 20, 133-136, 2005 | 122 | 2005 |
| Risk factors for long‐term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults K Ito, H Yotsuyanagi, H Yatsuhashi, Y Karino, Y Takikawa, T Saito, ... Hepatology 59 (1), 89-97, 2014 | 113 | 2014 |
| Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection MF Yuen, D Ka-Ho Wong, CK Lee, Y Tanaka, JP Allain, J Fung, J Leung, ... Clinical Infectious Diseases 52 (5), 624-632, 2011 | 113 | 2011 |
| Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system T Kato, T Date, M Miyamoto, M Sugiyama, Y Tanaka, E Orito, T Ohno, ... Journal of clinical microbiology 43 (11), 5679-5684, 2005 | 111 | 2005 |
| Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma V Kumar, PH Yi Lo, H Sawai, N Kato, A Takahashi, Z Deng, Y Urabe, ... Public Library of Science 7 (9), e44743, 2012 | 107 | 2012 |
| Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations T Sakamoto, Y Tanaka, J Simonetti, C Osiowy, ML Borresen, A Koch, ... The Journal of infectious diseases 196 (10), 1487-1492, 2007 | 101 | 2007 |
| Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for … Y Tanaka, M Kurosaki, N Nishida, M Sugiyama, K Matsuura, N Sakamoto, ... Human molecular genetics 20 (17), 3507-3516, 2011 | 99 | 2011 |
| A novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptide M Kaneko, K Watashi, S Kamisuki, H Matsunaga, M Iwamoto, F Kawai, ... Journal of virology 89 (23), 11945-11953, 2015 | 98 | 2015 |
| Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease E Kumagai, Y Mano, S Yoshio, H Shoji, M Sugiyama, M Korenaga, ... Scientific reports 6 (1), 35282, 2016 | 97 | 2016 |
